Ryanodine receptor dysfunction and triggered activity in the heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 5, 2007, Pages

  Katra, Rodolphe P ^a,c   Oya, Toshiyuki ^a,d   Hoeker, Gregory S ^a   Laurita, Kenneth R ^a,b  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Cardiac Disease Management   (United States)

^d NONE   (Japan)

Author keywords

Arrhythmia mechanisms; Spontaneous calcium release; Sudden death

Indexed keywords

CALCIUM; ISOPRENALINE; RAPAMYCIN; RYANODINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOG; ENDOCARDIUM; EPICARDIUM; HEART ARRHYTHMIA; HEART LEFT VENTRICLE; HEART PACING; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA; ANIMAL; CALCIUM SIGNALING; CELL MEMBRANE POTENTIAL; HEART; HEART MUSCLE CONDUCTION SYSTEM; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ARRHYTHMIA; CALCIUM; CALCIUM SIGNALING; DOGS; HEART; HEART CONDUCTION SYSTEM; MEMBRANE POTENTIALS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 34250869496     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00924.2006     Document Type: Article

References (49)

1. Ahern GP, Junankar PR, Dulhunty AF. Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12. Biophys J 72: 146-162, 1997.
2. Allen PD. Not all sudden death is the same. Circ Res 93: 484-486, 2003.
3. 2+ homeostasis. Am J Physiol Heart Circ Physiol 289: H1584-H1593, 2005.
4. Chelu MG, Danila CI, Gilman CP, Hamilton SL. Regulation of ryanodine receptors by FK506 binding proteins. Trends Cardiovasc Med 14: 227-234, 2004.
5. Chen PS. Ryanodine receptor gene and familial (catecholaminergic) polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 12: 506, 2001.
6. Cordeiro JM, Greene L, Heilmann C, Antzelevitch D, Antzelevitch C. Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle. Am J Physiol Heart Circ Physiol 286: H1471-H1479, 2004.
7. 2+ release. J Physiol 501: 3-16, 1997.
8. + currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycin. Am J Physiol Heart Circ Physiol 278: H886-H897, 2000.
9. Firoozi S, Sharma S, Hamid MS, McKenna WJ. Sudden death in young athletes: HCM or ARVC? Cardiovasc Drugs Ther 16: 11-17, 2002.
10. Hasenfuss G, Seidler T. Treatment of heart failure through stabilization of the cardiac ryanodine receptor. Circulation 107: 378-380, 2003.
11. 2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res 97: 1173-1181, 2005.
12. Johnson N, Danilo P Jr, Wit AL, Rosen MR. Characteristics of initiation and termination of catecholamine-induced triggered activity in atrial fibers of the coronary sinue. Circulation 74: 1168-1179, 1986.
13. 2+-release channels from cardiac muscle. Circ Res 78: 990-997, 1996.
14. Katra RP, Laurita KR. Cellular mechanism of calcium-mediated triggered activity in the heart. Circ Res 96: 535-542, 2005.
15. Katra RP, Pruvot E, Laurita KR. Intracellular calcium handling heterogeneities in intact guinea pig hearts. Am J Physiol Heart Circ Physiol 286: H648-H656, 2004.
16. Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A, Lorber A, Kastner DL, Goldman B, Pras E. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 103: 2822-2827, 2001.
17. Lahat H, Pras E, Eldar M. RYR2 and CASQ2 mutations in patients suffering from catecholaminergic polymorphic ventricular tachycardia. Circulation 107: E29, 2003.
18. Laurita KR, Katra R, Wible B, Wan X, Koo MH. Transmural heterogeneity of calcium handling in canine. Circ Res 92: 668-675, 2003.
19. Laurita KR, Katra RP. Delayed afterdepolarization-mediated triggered activity associated with slow calcium sequestration near the endocardium. J Cardiovasc Electrophysiol 16: 418-424, 2005.
20. Laurita KR, Singal A. Mapping action potentials and calcium transients simultaneously from the intact heart. Am J Physiol Heart Circ Physiol 280: H2053-H2060, 2001.
21. Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109: 3208-3214, 2004.
22. Li YX, Kranias EG, Mignery GA, Bers DM. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res 90: 309-316, 2002.
23. Lukyanenko V, Györke I, Gyo̊rke S. Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes. Pflůgers Arch 432: 1047-1054, 1996.
24. 2+ uptake into the sarcoplasmic reticulum. Circ Res 89: 614-622, 2001.
25. Marks AR. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol 33: 615-624, 2001.
26. Marks AR. Clinical implications of cardiac ryanodine receptor/calcium release channel mutations linked to sudden cardiac death. Circulation 106: 8-10, 2002.
27. Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol 190: 1-6, 2002.
28. Marx SO, Gaburjakova J, Gaburjakova M, Henrikson C, Ondrias K, Marks AR. Coupled gating between cardiac calcium release channels (ryanodine receptors). Circ Res 88: 1151-1158, 2001.
29. 2+ transients in rat cardiac myocytes. Circ Res 79: 1110-1121, 1996.
30. Nam GB, Burashnikov A, Antzelevitch C. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation 111: 2727-2733, 2005.
31. Nishimura M, Kim K, Uchiyama A, Fujino Y, Nishimura S, Taenaka N, Mashimo T. Tacrolimus-induced life-threatening arrhythmia in a pediatric liver-transplant patient. Intensive Care Med 28: 1683-1684, 2002.
32. 2+ from the sarcoplasmic reticulum in rat ventricular myocytes. J Physiol 559: 121-128, 2004.
33. Pogwizd SM. Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation 90: 1441-1458, 1994.
34. Pogwizd SM, McKenzie JP, Cain ME. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 98: 2404-2414, 1998.
35. Prestle J, Dieterich S, Preuss M, Bieligk U, Hasenfuss G. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 43: 323-331, 1999.
36. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz FES, Vignati G, Benatar A, DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106: 69-74, 2002.
37. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103: 196-200, 2001.
38. Pruvot EJ, Katra RP, Rosenbaum DS, Laurita KR. Role of calcium cycling versus restitution in the mechanism of repolarization alternans. Circ Res 94: 1083-1090, 2004.
39. Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, D'Armiento J, Burkhoff D, Wang J, Vassort G, Lederer WJ, Marks AR. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts - Role of phosphatases and response to isoproterenol. J Biol Chem 278: 444-453, 2003.
40. Scoote M, Williams AJ. The cardiac ryanodine receptor (calcium release channel): emerging role in heart failure and arrhythmia pathogenesis. Cardiovasc Res 56: 359-372, 2002.
41. Seidler T, Miller SL, Loughrey CM, Kania A, Burow A, Kettlewell S, Teucher N, Wagner S, Kogler H, Meyers MB, Hasenfuss G, Smith GL. Effects of adenovirus-mediated sorcin overexpression on excitation-contraction coupling in isolated rabbit cardiomyocytes. Circ Res 93: 132-139, 2003.
42. 2+) differ in mouse and rabbit ventricular myocytes. J Pharmacol Exp Ther 304: 334-341, 2003.
43. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10: 189-194, 2001.
44. Wan X, Laurita KR, Pruvot E, Rosenbaum DS. Molecular correlates of repolarization alternans in cardiac myocytes. J Mol Cell Cardiol 39: 419-428, 2005.
45. Wehrens XHT, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, D'Armiento JM, Napolitano C, Memmi M, Priori SG, Lederer WJ, Marks AR. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113: 829-840, 2003.
46. +-channel activation and membrane hyperpolarization in bladder smooth muscle. Br J Pharmacol 129: 1293-1300, 2000.
47. 2+ release channel closure in rat heart. J Physiol 500: 343-354, 1997.
48. Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 93: 372-379, 1996.
49. 2+ leak through ryanodine receptor in heart failure. Circulation 102: 2131-2136, 2000.